<DOC>
	<DOCNO>NCT00267774</DOCNO>
	<brief_summary>In multicenter , international study evaluate two approach determine coronary artery narrowing require stent placement patient multivessel coronary artery disease . Patients randomized angiographic strategy , coronary angiography use determine lesion stent pressure wire strategy fractional flow reserve , index measure pressure wire , use determine lesion stent . The primary outcome major adverse cardiac event 1 year . A secondary outcome cost-effectiveness .</brief_summary>
	<brief_title>Fractional Flow Reserve Versus Angiography Multivessel Evaluation ( F.A.M.E . )</brief_title>
	<detailed_description>Detailed protocol - If patient eligible study ( see inclusion exclusion criterion ) give informed consent , operator define lesion stenosis severity least 50 % visual estimate would consider stent implantation . These stenosis note scheme coronary artery randomization . - Thereafter , randomization perform FFR-guided strategy angiography-guided strategy . If patient randomize angiography-guided strategy , lesion indicate beforehand , stented drug-eluting stent . If patient assign FFR-guided group , fractional flow reserve measure lesion lesion stented fractional flow reserve &lt; /=0.80 . Treatment PCI accord local routine include least aspirin 80 mg daily clopidogrel ( Plavix ) 75 mg per day least 12months . - FFR determine use i.v . adenosine 140 µg/kg/min , order make pull-back recording analyze different abnormality along coronary artery . Adenosine i.v . femoral venous route , mandatory participation study . - In case serial stenosis , FFR 'of complete vessel ' &lt; /= 0.80 warrant PCI one lesions case patient belongs FFR-guided group . In case angio-guided group , every lesion &gt; 50 % visual estimation operator indicate prior require stenting , stented ( mandatory ) . Long stent cover segment multiple shorter stent , place discretion operator . Follow-up All patient follow 1 month ( ±1 week ) , 6 month ( ±1 month ) , 1 year ( ±1 month ) . All adverse cardiac event ( death , acute MI , CABG [ ] -PCI note , well functional class number anti-anginal drug . If patient admit hospital acute coronary syndrome , repeat angiography strongly advocate define event relate one deferred lesion one non-deferred lesion . If patient belongs FFR-guided arm , repeat measurement FFR advocate lesion . If , follow-up , patient FFR-guided group undergo coronary angiography recurrent angina reason without event , pressure measurement repeat well . On contrary , patient assign angiographic guide group , strategy follow consistently follow-up investigation . For example , patient angiographic guide arm recurrent chest pain , undergoes angiography , find in-stent restenosis , re-PCI perform base angiogram pressure wire use prohibit . In word , strategy patient assign initially , follow entire study period . Endpoints Primary endpoint 1 . The primary clinical endpoint 12-month binary major adverse cardiac event ( MACE ) rate . MACE define : - All cause death , - Documented myocardial infarction , - Repeat revascularization ( PCI and/or CABG ) adjudicate Clinical Event Committee Secondary endpoint 1 . Global cost effectiveness one year 2 . Cardiac death myocardial infarction rate 1 year 3 . Functional class 1 year . 4 . Number anti-anginal drug 1 year 5 . Overall MACE rate 1 month post-procedure 6 month , 2 , 3 5 year . 6 . A comparison outcomes base type drug-eluting stent . 7 . Prognostic value FFR stenting . 8 . Correlation FFR nuclear perfusion imaging .</detailed_description>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>least 2 coronary lesion 50 % stenosis great least 2 major epicardial artery age &gt; /=18 STEMI &lt; 5 day ago nonSTEMI CK &gt; 1000 U/l &lt; 5 day ago Pregnancy Extremely tortuous calcify coronary artery , technical condition interfere reliable coronary pressure measurement Serious concomitant disease , decrease life expectancy &lt; 2 year Previous coronary bypass surgery ( CABG ) Contraindication drugeluting stent Cardiogenic shock Inability give inform consent Suspicion significant leave main ( LM ) stenosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>